Other

Alnylam Pharmaceuticals·Balance Sheet Statement·22 metrics

Breakdown

Loading...

Metrics

Common stock, par value (in dollars per share)

Common stock, shares authorized (in shares)

Common stock, shares issued (in shares)

Common Stock, Shares, Outstanding

Convertible debentures

Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, Before Tax, Including Cash Equivalents

Gross Unrealized Gains

Debt Securities, Available-for-Sale, Amortized Cost, Including Cash Equivalents

Fair Value

Inventory, Current And Noncurrent

Raw materials

Loss Contingency Accrual

Number of commercialized products

Number of partnered products

Number of marketed products

Preferred Stock, Par or Stated Value Per Share

Preferred Stock, Shares Authorized

Preferred Stock, Shares Issued

Preferred Stock, Shares Outstanding

Restricted Investments, Noncurrent

Liabilities related to the sale of future royalties and development funding, net of current portion

Valuation Allowances And Reserves Balance